Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
118,527,341
-
Share change
-
+12,878,496
-
Total reported value
-
$695,947,780
-
Put/Call ratio
-
41%
-
Price per share
-
$6.03
-
Number of holders
-
96
-
Value change
-
+$72,414,501
-
Number of buys
-
50
-
Number of sells
-
36
Institutional Holders of IDENIX PHARMACEUTICALS INC - COM (IDIX) as of Q1 2014
As of 31 Mar 2014,
IDENIX PHARMACEUTICALS INC - COM (IDIX) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
118,527,341 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, BROOKSIDE CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Sarissa Capital Management LP, BlackRock Fund Advisors, State Street Corp, BlackRock Institutional Trust Company, N.A., Cormorant Asset Management, LLC, and Capital World Investors.
This page lists
96
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.